Advisors Asset Management Inc. Raises Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Advisors Asset Management Inc. boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 18.9% during the 3rd quarter, Holdings Channel.com reports. The firm owned 14,240 shares of the medical equipment provider’s stock after acquiring an additional 2,265 shares during the period. Advisors Asset Management Inc.’s holdings in Intuitive Surgical were worth $6,996,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. International Assets Investment Management LLC increased its holdings in shares of Intuitive Surgical by 49,383.6% in the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after acquiring an additional 1,088,415 shares during the last quarter. Capital Research Global Investors purchased a new position in shares of Intuitive Surgical in the 1st quarter valued at about $374,390,000. Strategic Financial Concepts LLC increased its holdings in shares of Intuitive Surgical by 40,221.4% in the 2nd quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock valued at $1,184,000 after acquiring an additional 265,461 shares during the last quarter. Canada Pension Plan Investment Board boosted its position in shares of Intuitive Surgical by 36.4% in the 1st quarter. Canada Pension Plan Investment Board now owns 807,780 shares of the medical equipment provider’s stock valued at $322,377,000 after purchasing an additional 215,444 shares during the period. Finally, Manning & Napier Advisors LLC acquired a new stake in shares of Intuitive Surgical in the 2nd quarter valued at about $91,466,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In related news, Director Amy L. Ladd sold 450 shares of Intuitive Surgical stock in a transaction on Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the transaction, the director now owns 821 shares in the company, valued at approximately $402,519.88. This trade represents a 35.41 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Henry L. Charlton sold 40,243 shares of Intuitive Surgical stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the transaction, the senior vice president now owns 3,001 shares in the company, valued at $1,461,006.84. The trade was a 93.06 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 91,178 shares of company stock worth $45,897,071 over the last quarter. 0.80% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of research analyst reports. Wells Fargo & Company upped their target price on Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research report on Friday, October 18th. BTIG Research set a $535.00 target price on Intuitive Surgical in a research report on Friday, October 18th. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Citigroup increased their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Finally, JPMorgan Chase & Co. increased their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $524.61.

Intuitive Surgical Stock Up 0.6 %

ISRG stock opened at $541.82 on Thursday. Intuitive Surgical, Inc. has a 52-week low of $304.50 and a 52-week high of $544.38. The stock’s fifty day simple moving average is $502.44 and its 200-day simple moving average is $461.26. The stock has a market capitalization of $192.98 billion, a price-to-earnings ratio of 87.11, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.